Is your question of a legal or tax nature, or both? What are the legal consequences of a particular tax structure and vice versa? More and more companies, financial institutions, governments and individuals are discovering the benefits of customised integrated advice.
As a leading firm, Loyens & Loeff is the logical choice as a legal and tax partner if you do business in or from the Netherlands, Belgium, Luxembourg or Switzerland, our home markets. You can count on personal advice from any of our 800 advisers based in one of our offices in the Benelux and Switzerland or in key financial centres around the world. Thanks to our full-service practice, specific sector experience and thorough understanding of the market, our advisers comprehend exactly what you need.
Exploration & Production
Yesterday the Council of State’s Administrative Jurisdiction Division (hereinafter: the Council) ruled in proceedings regarding the Ministerial consent of September 2016 (together with the amendment decision of May 2017) required for the 5 year production plan 2016 for the Groningen Field Concession.
InflaRx N.V., a clinical-stage biopharmaceutical company, placed 6,667,000 common shares in the IPO with a share price of $15.00 raising approximately $100 million of primary gross proceeds (total market capitalisation of $351,164,580). Trading of the shares on the NASDAQ Global Select Market commenced on 8 November 2017 under the ticker symbol “IFRX”.
Loyens & Loeff acted as Dutch corporate counsel to the underwriters. In this transaction Loyens & Loeff worked closely together with Goodwin Procter LLP.